Sling Brings Potential Oral Competition To Amgen’s Tepezza In TED

Older eye
Sling is looking to join the competition with Amgen in thyroid eye disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from Therapy Areas